Insufficient insulin secretion and/or utilisation is a major cause of T2DM and the insulin signalling pathway is the main pathway by which insulin acts on target cells to produce biological effects, with the insulin receptor (InsR) and the insulin-like growth factor receptor (IGF-1R) being important components of the insulin signalling pathway. The gene discussed is INSR; the disease is type 2 diabetes mellitus.